Document is current

Article History

Received: 14 January 2025

Accepted: 11 March 2025

First Online: 26 March 2025

Declarations

:

: This study was performed following the Declaration of Helsinki Ethical Principles and approved by the Ethics Committee of the Tianjin Medical University General Hospital, Tianjin, China (Approval number: IRB2024-YX-014–01). (1) Title of the approved project: Studies on the mechanism of human menstrual blood-derived endometrial regenerative cell exosomes in the therapy of ischaemia–reperfusion. (2) Name of the institutional approval committee: the Ethics Committee of the Tianjin Medical University General Hospital, Tianjin, China. (3) Approval number: IRB2024-YX-014–01. (4) Date of approval: 01/25/2024. After filling out the informed consent letter, All human menstrual blood samples were obtained from Tianjin Medical University General Hospital from healthy female volunteers (20–30 years of age). The animal care and experimental protocols were approved by the Institutional Animal Care and Use Committee of Tianjin Medical University General Hospital and and was conducted in accordance with the ARRIVE guidelines 2.0 (Project title: Studies on the mechanism of human menstrual blood-derived endometrial regenerative cell exosomes in the therapy of ischaemia–reperfusion; Approval number: IRB2024-DW-08; Date of approval: 01/30/2024).

: Not applicable.

: No potential conflict of interest was reported by the author(s).